Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-01-07 17:51:04
Bergen, Norway,7 January 2022 -BerGenBioASA (OSE: BGBIO) (the "Company"), has been notified that Martin Olin, CEO and primary insider of BerGenBio ASA, has bought 10,000 shares in BerGenBio ASA at an average price of NOK 20.43 per share. After the transaction Mr. Olin holds 28,000 shares in BerGenBio ASA.
Please see the attached document for further details of the transaction.
Contact:
ir@bergenbio.com
RuneSkeie, CFO,BerGenBioASA
rune.skeie@bergenbio.com
This information issubject to the disclosure requirements pursuant to the EU Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities Trading Act.